Rankings
▼
Calendar
RGEN FY 2016 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
FY 2016 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$105M
+25.1% YoY
Gross Profit
$57M
54.9% margin
Operating Income
$16M
15.3% margin
Net Income
$12M
11.2% margin
EPS (Diluted)
$0.34
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$3M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$289M
Total Liabilities
$120M
Stockholders' Equity
$169M
Cash & Equivalents
$142M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$105M
$84M
+25.1%
Gross Profit
$57M
$48M
+18.9%
Operating Income
$16M
$14M
+16.1%
Net Income
$12M
$9M
+25.0%
← FY 2015
All Quarters
Q1 2016 →